Ischemic Heart Disease: LV Risk, Plaque Types & Treatment

Ischemic heart disease (IHD) is a critical medical condition, currently ranking as the number one cause of death for both males and females in the USA and other industrialized countries. It is not a single condition but a group of clinical pathological syndromes resulting from an imbalance between oxygen supply and demand to the myocardium. Typically, this means oxygen supply is reduced, or oxygen demand is increased, leading to relative ischemia of the heart muscle.

Understanding Ischemia vs. Hypoxemia

In a healthy heart, there's a balance between oxygen and nutrient supply and demand. IHD occurs when this balance is disrupted, leading to myocardial ischemia. It's crucial to differentiate between ischemia and isolated hypoxemia:

Ischemia

Ischemia signifies reduced blood flow to an area, often due to a fixed obstruction like an atherosclerotic plaque in a coronary artery. It has three key features: 1. Reduced oxygen supply: Less oxygen reaches the dependent myocardium. 2. Reduced other nutrients: Essential nutrients like fatty acids and glucose are also diminished. 3. Impaired washout of metabolic wastes: The reduced blood flow means metabolic byproducts accumulate, further damaging the tissue.

Ischemia is considered more dangerous than simple hypoxemia due to this triple impact.

Isolated Hypoxemia

In isolated hypoxemia, only oxygen supply is reduced, while blood flow, other nutrient delivery, and waste removal remain relatively normal. Conditions leading to isolated hypoxemia include: * Severe anemia: Reduced oxygen-carrying capacity of the blood due to low hemoglobin. * Severe pulmonary diseases: Impaired oxygenation of blood in the lungs. * Cyanotic heart disease: Right-to-left shunting of blood within the heart, leading to deoxygenated blood mixing with oxygenated blood in the arterial tree.

While isolated hypoxemia can cause IHD manifestations, its effects are generally less deleterious than true ischemia.

Why the Left Ventricle is More Vulnerable to Ischemia

IHD predominantly affects the left ventricle (LV) in 98-99% of cases. This is due to several anatomical and physiological reasons:

• Thickness and Oxygen Needs: The LV wall is significantly thicker (about 1.5 cm) than the right ventricle (RV) wall (0.3-0.5 cm). This greater muscle mass means the LV has higher oxygen requirements.
• Workload and Tension: The LV generates much higher pressures (0 to 125 mmHg) to pump blood to the entire body, compared to the RV (0 to 25 mmHg) which pumps to the lungs. This higher workload and tension in the LV wall translate to greater oxygen demand.
• Systolic Compression of Microcirculation: During systole (contraction), the LV muscles contract so forcefully that they squeeze and impede their own microcirculation. This means the LV receives virtually no blood flow during systole, relying almost entirely on diastole for its blood supply. In contrast, the RV, generating less tension, impedes its microcirculation less severely and receives blood flow during both systole and diastole.

Therefore, the LV has higher oxygen demands and a more compromised blood supply during contraction, making it far more vulnerable to ischemia. RV ischemia is rare, typically occurring only in cases of severe RV hypertrophy (e.g., cor pulmonale) or reduced blood flow through the right coronary artery.

Causes of Reduced Blood Flow to the Myocardium

The primary cause of reduced blood flow to the myocardium is atherosclerosis in the coronary arteries. Atheromas, or fibro-fatty plaques, form in the intima of these arteries.

Stable Atherosclerotic Plaques (Fixed Obstruction)

• Formation: Plaques develop over years, starting with fatty dots and streaks in adolescence.
• Obstruction: These plaques progressively grow, causing a fixed obstruction to blood flow.
• Symptom Threshold: Ischemia typically doesn't occur at rest until the plaque obstructs more than 70% of the lumen.
  • 70% Obstruction: Symptoms (like angina) usually appear only during increased oxygen demand (e.g., physical exertion, emotional stress, tachycardia, hypertension), as the remaining 30% flow is insufficient to meet the increased needs.
  • 90% Obstruction: Ischemia and symptoms can occur even at rest.
• Clinical Manifestation: Stable plaques are the hallmark of typical or stable angina, where symptoms are predictable and related to exertion.

Unstable Atherosclerotic Plaques (Dynamic Obstruction)

These plaques are more dangerous and can undergo rapid, dynamic changes. They are often characterized by: * Composition: Less fibrous tissue, a thin fibrous cap, more extracellular fat, more foam cells (lipid-laden macrophages), and more macrophages. * Vulnerability: Macrophages release metalloproteinases that digest fibrous material, weakening the plaque and making it susceptible to disruption.

Acute disruptions in vulnerable plaques can lead to:

1. Erosions and Ulcerations: Damage to the dysfunctional endothelium, exposing the underlying thrombogenic basement membrane.
2. Fissuring and Rupture: More severe damage where the plaque's lipid core is exposed to the bloodstream. This is more dangerous.
3. Intra-plaque Hemorrhage: New, weak blood vessels (neovascularization) at the plaque's shoulder can rupture, or blood can seep in from luminal fissures, causing the plaque to swell rapidly and acutely obstruct the artery.

Consequences of Plaque Disruption

When a plaque disrupts, it triggers a cascade of events: * Platelet Adhesion: Platelets stick to the exposed thrombogenic surface (sub-endothelial collagen or lipid core). * Platelet Release Reaction: Adherent platelets release factors (e.g., ADP, serotonin, epinephrine, procoagulants) that attract more platelets. * Platelet Aggregation: More platelets stick to each other, forming a platelet aggregate (platelet plug). * Coagulation and Thrombus Formation: In some cases, tissue factors are released, activating the coagulation cascade. This converts soluble fibrinogen into insoluble fibrin strands, which deposit on the platelet plug, forming a thrombus.

These processes lead to dynamic obstruction of the coronary artery lumen. The obstruction can fluctuate as platelet plugs or thrombi form, grow, or even spontaneously lyse. A thrombus can also detach and embolize, blocking a distal part of the artery (thromboembolism).

Most Vulnerable Point of Plaque Rupture

Plaques most often rupture at the junction where the fibrous cap meets the normal arterial wall (the "shoulder" of the plaque). This is because: * The fibrous cap is thinnest at these margins. * Macrophage activity is concentrated here, releasing enzymes that weaken the cap. * Hemodynamic shear stresses are highest at these points.

Therapeutic Implications

• Statins: These lipid-lowering drugs are crucial in managing atherosclerosis.
  • Cholesterol Reduction: They reduce cholesterol levels, decreasing lipid accumulation in plaques and making them more stable.
  • Anti-inflammatory Action: Statins also have anti-inflammatory effects, reducing macrophage activity in plaques. This preserves the fibrous cap, making plaques less vulnerable to rupture and potentially leading to plaque regression.
• Smoking Cessation: Tobacco smoke significantly increases the likelihood of platelets sticking to disrupted plaques, exacerbating the risk of thrombus formation and severe ischemic events.